Click for best price
Healthcare Nanotechnology Nanomedicine Market Size, Share 2022
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
This report contains market size and forecasts of Healthcare Nanotechnology (Nanomedicine) in Global, including the following market information:
Global Healthcare Nanotechnology (Nanomedicine) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Healthcare Nanotechnology (Nanomedicine) market was valued at 200560 million in 2021 and is projected to reach US$ 371070 million by 2028, at a CAGR of 9.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanomedicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Healthcare Nanotechnology (Nanomedicine) include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare Nanotechnology (Nanomedicine) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare Nanotechnology (Nanomedicine) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Healthcare Nanotechnology (Nanomedicine) Market Segment Percentages, by Type, 2021 (%)
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Healthcare Nanotechnology (Nanomedicine) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Healthcare Nanotechnology (Nanomedicine) Market Segment Percentages, by Application, 2021 (%)
Anticancer
CNS Product
Anti-infective
Other
Global Healthcare Nanotechnology (Nanomedicine) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Healthcare Nanotechnology (Nanomedicine) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Healthcare Nanotechnology (Nanomedicine) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Healthcare Nanotechnology (Nanomedicine) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
SmitH& Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
| Report Attributes |
Report Details |
| Report Title |
Healthcare Nanotechnology (Nanomedicine) Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Healthcare Nanotechnology (Nanomedicine) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare Nanotechnology (Nanomedicine) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare Nanotechnology (Nanomedicine) Overall Market Size
2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size: 2021 VS 2028
2.2 Global Healthcare Nanotechnology (Nanomedicine) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare Nanotechnology (Nanomedicine) Players in Global Market
3.2 Top Global Healthcare Nanotechnology (Nanomedicine) Companies Ranked by Revenue
3.3 Global Healthcare Nanotechnology (Nanomedicine) Revenue by Companies
3.4 Top 3 and Top 5 Healthcare Nanotechnology (Nanomedicine) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Healthcare Nanotechnology (Nanomedicine) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare Nanotechnology (Nanomedicine) Players in Global Market
3.6.1 List of Global Tier 1 Healthcare Nanotechnology (Nanomedicine) Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare Nanotechnology (Nanomedicine) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Healthcare Nanotechnology (Nanomedicine) Market Size Markets, 2021 & 2028
4.1.2 Nanomedicine
4.1.3 Nano Medical Devices
4.1.4 Nano Diagnosis
4.1.5 Other
4.2 By Type - Global Healthcare Nanotechnology (Nanomedicine) Revenue & Forecasts
4.2.1 By Type - Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2022
4.2.2 By Type - Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2023-2028
4.2.3 By Type - Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Healthcare Nanotechnology (Nanomedicine) Market Size, 2021 & 2028
5.1.2 Anticancer
5.1.3 CNS Product
5.1.4 Anti-infective
5.1.5 Other
5.2 By Application - Global Healthcare Nanotechnology (Nanomedicine) Revenue & Forecasts
5.2.1 By Application - Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2022
5.2.2 By Application - Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2023-2028
5.2.3 By Application - Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Healthcare Nanotechnology (Nanomedicine) Market Size, 2021 & 2028
6.2 By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue & Forecasts
6.2.1 By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2022
6.2.2 By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2023-2028
6.2.3 By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2028
6.3.2 US Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.3.3 Canada Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.3.4 Mexico Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2028
6.4.2 Germany Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4.3 France Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4.4 U.K. Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4.5 Italy Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4.6 Russia Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4.7 Nordic Countries Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.4.8 Benelux Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2028
6.5.2 China Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.5.3 Japan Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.5.4 South Korea Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.5.5 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.5.6 India Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2028
6.6.2 Brazil Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.6.3 Argentina Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2028
6.7.2 Turkey Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.7.3 Israel Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.7.4 Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
6.7.5 UAE Healthcare Nanotechnology (Nanomedicine) Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.1.4 Amgen Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Corporate Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.2.4 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceuticals Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.3.4 Abbott Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 UCB
7.4.1 UCB Corporate Summary
7.4.2 UCB Business Overview
7.4.3 UCB Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.4.4 UCB Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.4.5 UCB Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.5.4 Roche Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.6.4 Celgene Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.6.5 Celgene Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.7.4 Sanofi Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Merck & Co
7.8.1 Merck & Co Corporate Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.8.4 Merck & Co Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.8.5 Merck & Co Key News
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.9.4 Biogen Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.9.5 Biogen Key News
7.10 Stryker
7.10.1 Stryker Corporate Summary
7.10.2 Stryker Business Overview
7.10.3 Stryker Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.10.4 Stryker Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.10.5 Stryker Key News
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporate Summary
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.11.4 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.11.5 Gilead Sciences Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.12.4 Pfizer Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.12.5 Pfizer Key News
7.13 3M Company
7.13.1 3M Company Corporate Summary
7.13.2 3M Company Business Overview
7.13.3 3M Company Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.13.4 3M Company Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.13.5 3M Company Key News
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Corporate Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.14.4 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.14.5 Johnson & Johnson Key News
7.15 SmitH& Nephew
7.15.1 SmitH& Nephew Corporate Summary
7.15.2 SmitH& Nephew Business Overview
7.15.3 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.15.4 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.15.5 SmitH& Nephew Key News
7.16 Leadiant Biosciences
7.16.1 Leadiant Biosciences Corporate Summary
7.16.2 Leadiant Biosciences Business Overview
7.16.3 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.16.4 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.16.5 Leadiant Biosciences Key News
7.17 Kyowa Hakko Kirin
7.17.1 Kyowa Hakko Kirin Corporate Summary
7.17.2 Kyowa Hakko Kirin Business Overview
7.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.17.4 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.17.5 Kyowa Hakko Kirin Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.18.4 Takeda Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.18.5 Takeda Key News
7.19 Ipsen
7.19.1 Ipsen Corporate Summary
7.19.2 Ipsen Business Overview
7.19.3 Ipsen Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.19.4 Ipsen Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.19.5 Ipsen Key News
7.20 Endo International
7.20.1 Endo International Corporate Summary
7.20.2 Endo International Business Overview
7.20.3 Endo International Healthcare Nanotechnology (Nanomedicine) Major Product Offerings
7.20.4 Endo International Healthcare Nanotechnology (Nanomedicine) Revenue in Global Market (2017-2022)
7.20.5 Endo International Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Healthcare Nanotechnology (Nanomedicine) Market Opportunities & Trends in Global Market
Table 2. Healthcare Nanotechnology (Nanomedicine) Market Drivers in Global Market
Table 3. Healthcare Nanotechnology (Nanomedicine) Market Restraints in Global Market
Table 4. Key Players of Healthcare Nanotechnology (Nanomedicine) in Global Market
Table 5. Top Healthcare Nanotechnology (Nanomedicine) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Healthcare Nanotechnology (Nanomedicine) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Healthcare Nanotechnology (Nanomedicine) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Healthcare Nanotechnology (Nanomedicine) Product Type
Table 9. List of Global Tier 1 Healthcare Nanotechnology (Nanomedicine) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare Nanotechnology (Nanomedicine) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Healthcare Nanotechnology (Nanomedicine) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Healthcare Nanotechnology (Nanomedicine) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Healthcare Nanotechnology (Nanomedicine) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Healthcare Nanotechnology (Nanomedicine) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 32. Amgen Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceuticals Corporate Summary
Table 34. Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 35. Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 38. Abbott Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 39. UCB Corporate Summary
Table 40. UCB Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 41. UCB Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 44. Roche Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporate Summary
Table 46. Celgene Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 47. Celgene Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 50. Sanofi Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co Corporate Summary
Table 52. Merck & Co Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 53. Merck & Co Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 54. Biogen Corporate Summary
Table 55. Biogen Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 56. Biogen Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 57. Stryker Corporate Summary
Table 58. Stryker Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 59. Stryker Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 60. Gilead Sciences Corporate Summary
Table 61. Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 62. Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 65. Pfizer Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 66. 3M Company Corporate Summary
Table 67. 3M Company Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 68. 3M Company Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 69. Johnson & Johnson Corporate Summary
Table 70. Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 71. Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 72. SmitH& Nephew Corporate Summary
Table 73. SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 74. SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 75. Leadiant Biosciences Corporate Summary
Table 76. Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 77. Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 78. Kyowa Hakko Kirin Corporate Summary
Table 79. Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 80. Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 81. Takeda Corporate Summary
Table 82. Takeda Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 83. Takeda Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 84. Ipsen Corporate Summary
Table 85. Ipsen Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 86. Ipsen Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
Table 87. Endo International Corporate Summary
Table 88. Endo International Healthcare Nanotechnology (Nanomedicine) Product Offerings
Table 89. Endo International Healthcare Nanotechnology (Nanomedicine) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Healthcare Nanotechnology (Nanomedicine) Segment by Type in 2021
Figure 2. Healthcare Nanotechnology (Nanomedicine) Segment by Application in 2021
Figure 3. Global Healthcare Nanotechnology (Nanomedicine) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Healthcare Nanotechnology (Nanomedicine) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Healthcare Nanotechnology (Nanomedicine) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare Nanotechnology (Nanomedicine) Revenue in 2021
Figure 8. By Type - Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 12. US Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 16. Germany Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 17. France Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 24. China Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 28. India Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 30. Brazil Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Revenue Market Share, 2017-2028
Figure 33. Turkey Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Healthcare Nanotechnology (Nanomedicine) Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. UCB Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogen Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Stryker Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. 3M Company Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Takeda Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Ipsen Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Endo International Healthcare Nanotechnology (Nanomedicine) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
